NYSE:TMOLife Sciences
Is Thermo Fisher (TMO) Turning Its AI Lab Platform Into a Durable Competitive Moat?
Earlier this week at the BIO International Convention 2026 in San Diego, Thermo Fisher Scientific showcased upgrades to its Orbitrap mass spectrometry platform, new AI-powered software, and integrated laboratory solutions aimed at supporting complex research and biopharma development.
This push to act as a single, AI-enabled partner across drug discovery, clinical development, and bioproduction highlights Thermo Fisher’s effort to deepen its role in end-to-end pharmaceutical workflows.
We’ll...

